Welcome to our dedicated page for E-Buy Home news (Ticker: EBYH), a resource for investors and traders seeking the latest updates and insights on E-Buy Home stock.
E-BUY HOME INC (OTC: EBYH), doing business as Strainsforpains, Inc., features frequent news updates that describe its activities in healthcare data technology, cannabinoid-based products, and artificial intelligence. Company press releases highlight developments in its proprietary medical cannabis app, CBD product commercialization, and collaborations with research institutions and biotech partners.
News items commonly focus on Strainsforpains’ AI-driven healthcare app, which the company states is designed to help doctors, nurses, dispensaries, and patients compare cannabis strains and cannabinoid combinations with major illnesses. Updates also cover collaborations with institutions such as Mt. Sinai in New York City and Johns Hopkins in Baltimore, where the company reports working on advanced AI data integrations and professional analytics for pain management and other critical ailments.
Another key theme in EBYH news is the commercialization of CBD products. Releases describe distribution orders for CBD body creams through pharmacies, wellness centers, and CBD and health markets in the New York City and Tri-State area, as well as plans for ingestible products and the use of water-soluble, nanoliposomal encapsulation technology. The company also reports partnerships with hemp farmers in Virginia and Pennsylvania and the use of its Pennsylvania facility for production and storage.
Investors and observers following EBYH news will also see coverage of strategic agreements with Cannabis Science, Inc. and GenBio, along with event and media initiatives such as the 1-Million Strong Killing Cancers, Fight Club MMA series and related fundraising efforts. Together, these updates provide insight into how Strainsforpains presents its progress in AI healthcare tools, cannabinoid research collaborations, product launches, and awareness campaigns.
For those tracking EBYH, the news stream offers ongoing context on the company’s stated strategy in health, wellness, medical cannabis, and AI-enabled data technology.
Strainsforpains, Inc. (OTC Markets: EBYH) has signed a letter of intent to acquire Cannasphere Biotech, LLC, an Arizona-based developer of innovative water-soluble cannabinoid products. This acquisition aims to enhance Strainsforpains' position in the growing cannabis and CBD markets through Cannasphere's proprietary technology and established industry relationships. The deal is projected to expand Strainsforpains' revenue streams and provide the necessary capital for Cannasphere's growth, allowing it to introduce transformative products into the market, while also improving margins and contract procurement.